Evidence map›Paper›PMID 40285868›Full record

ArticleMolecules (Basel, Switzerland)2025

Evaluation of Kinetic Models for the Catalytic Hydrogenation of Levulinic Acid to γ-Valerolactone over Nickel Catalyst Supported by Titania.

Carlos Alberto Sepulveda Lanziano, Cristiane Barbieri Rodella, Reginaldo Guirardello

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Carlos Alberto Sepulveda LanzianoSchool of Chemical Engineering, University of Campinas, Av. Albert Einstein n. 500, Campinas 13083-852, Brazil.
Cristiane Barbieri RodellaBrazilian Synchrotron Light Laboratory (LNLS), Brazilian Center for Research in Energy and Materials (CNPEM), R. Giuseppe Máximo Scolfaro n. 10000, Campinas 13083-100, Brazil.
Reginaldo GuirardelloSchool of Chemical Engineering, University of Campinas, Av. Albert Einstein n. 500, Campinas 13083-852, Brazil.ORCID 0000-0001-9458-0808

Funding

Coordenação de Aperfeicoamento de Pessoal de Nível Superior not available
6 · The paper itself

Abstract

The search for alternative sources of, and substitutes for, chemicals derived from fossil-based feedstocks encourages studies of heterogeneous catalysts to increase the feasibility of sustainable production of biomass derivatives, such as γ-valerolactone, among others. In this context, first, the performance of a titania-supported nickel catalyst (a non-noble catalyst) was evaluated in the reaction of hydrogenation of levulinic acid to γ-valerolactone in water using molecular hydrogen. The methods used included the synthesis of titania via the solgel method and nickel deposition by deposition-precipitation via removal of the complexing agent. The nickel was activated in a flow of hydrogen; the temperature of reduction and the calcination step were investigated with experiments at reaction conditions to study the catalyst's stability. Then, after a statistical evaluation of several proposed kinetic models, the kinetics of the reaction was found to be best represented by a model obtained considering that the reaction over the surface was the determinant step, followed by the non-dissociative adsorption of hydrogen and the competitive adsorption among hydrogen, levulinic acid, and γ-valerolactone. With that model, the activation energy of the levulinic acid to 4-hydroxypentanoic acid step was (47.0 ± 1.2) kJ mol

Indexed as

biomass conversionheterogeneous catalysishydrogenationkinetic studylevulinic acidnickeltitaniaγ-valerolactone

Identifiers

PMID40285868
PMCPMC11990501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.